EE149 Cost-Effectiveness of Cladribine Tablets and Dimethyl Fumarate in the Treatment of Relapsing Remitting Multiple Sclerosis in Spain

Autor: R Ginestal, O Duran, C Rubio Terrés, D Rubio-Rodríguez, H De Los Santos, C Ordoñez, I Sánchez

Publikováno v: Value in Health. 25:S82

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8ad26abddc8fe60c68a34690884e6946
https://doi.org/10.1016/j.jval.2022.09.401

Prospective, multicenter study on the economic and clinical impact of gene-expression assays in early-stage breast cancer from a single region: the PREGECAM registry experience

Autor: P. Zamora Auñon, M. del Monte-Millán, M. Arroyo Yustos, J. A. Guerra Martínez, S. García Adrián, José A. García-Sáenz, Y. Izarzugaza Perón, E.M. Ciruelos Gil, V. Valentín Maganto, C. Bueno Muiño, C. Jara Sánchez, I. Márquez-Rodas, S. Perez Ramirez, M. Á. Lara Álvarez, L. Manso Sánchez, F. Lobo Samper, J. R. Carrión Galindo, D. Rubio Rodríguez, M. Martin, M.J. Echarri González, N. Martínez Jañez, Sara López-Tarruella, C. Rubio Terres, F. Moreno Antón

Publikováno v: Clinicaltranslational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 22(5)

The aim of this study is to evaluate the cost-effectiveness and impact of gene-expression assays (GEAs) on treatment decisions in a real-world setting of early-stage breast cancer (ESBC) patients. This is a regional, prospective study promoted by the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51232aa6cb38c29616a162aa45863ed7
https://pubmed.ncbi.nlm.nih.gov/31300934

Economic Analysis of Thrombo inCode, a Clinical–Genetic Function for Assessing the Risk of Venous Thromboembolism

Autor: J. M. Soria, J. Sala, C. Rubio-Terrés, D. Rubio-Rodríguez, P. Suchon, J. Mateo, Sara Pich, Pierre Morange, E. Salas, Noémie Saut, Alfredo Gracia, Joan Carles Souto

Publikováno v: Applied Health Economics and Health Policy
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname

Background: Patients with venous thromboembolism (VTE) commonly have an underlying genetic predisposition. However, genetic tests nowadays in use have very low sensitivity for identifying subjects at risk of VTE. Thrombo inCode® is a new genetic too

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b59055a3960ebb815ac957d305c45fac
https://doi.org/10.1007/s40258-015-0153-x

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.